IE44190L - Glucosamine derivatives - Google Patents
Glucosamine derivativesInfo
- Publication number
- IE44190L IE44190L IE762689A IE268976A IE44190L IE 44190 L IE44190 L IE 44190L IE 762689 A IE762689 A IE 762689A IE 268976 A IE268976 A IE 268976A IE 44190 L IE44190 L IE 44190L
- Authority
- IE
- Ireland
- Prior art keywords
- glucosamine derivatives
- increase
- glucosamine
- derivatives
- gb1570625a
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Glucosamine derivatives of the formula <IMAGE> (X, R, R1, R2, R4, R6-R9 have the meaning stated in Claim 1) are prepared by condensation of corresponding 3-O-carboxymethylglucopyranosides with corresponding dipeptides. These glucosamine derivatives have the ability to increase the immunogenicity of an antigen on admixture therewith and, on systemic administration, to enhance the immunological reactivity of the treated organism. They can thus be used as adjuvants to increase the vaccine protection from bacterial, viral or parasitic pathogens.
[GB1570625A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1604275A CH613709A5 (en) | 1975-12-10 | 1975-12-10 | Process for the preparation of glucosamine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
IE44190L true IE44190L (en) | 1977-06-10 |
IE44190B1 IE44190B1 (en) | 1981-09-09 |
Family
ID=4414012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2689/76A IE44190B1 (en) | 1975-12-10 | 1976-12-09 | Glucosamine derivatives and a process for their manufacture |
Country Status (30)
Country | Link |
---|---|
JP (1) | JPS5273820A (en) |
AR (2) | AR224091A1 (en) |
AT (1) | AT365607B (en) |
AU (1) | AU508764B2 (en) |
BE (1) | BE849214A (en) |
CA (1) | CA1262400A (en) |
CH (2) | CH613709A5 (en) |
CS (4) | CS205027B2 (en) |
DD (1) | DD129781A5 (en) |
DE (1) | DE2655500A1 (en) |
DK (1) | DK154654C (en) |
ES (2) | ES454118A1 (en) |
FI (1) | FI64164C (en) |
FR (1) | FR2361902A1 (en) |
GB (1) | GB1570625A (en) |
GR (1) | GR61647B (en) |
HK (1) | HK32883A (en) |
HU (1) | HU177970B (en) |
IE (1) | IE44190B1 (en) |
IL (1) | IL51076A (en) |
MY (1) | MY8400123A (en) |
NL (1) | NL7613666A (en) |
NO (1) | NO144850C (en) |
NZ (1) | NZ182837A (en) |
PL (4) | PL110787B1 (en) |
PT (1) | PT65946B (en) |
SE (1) | SE445923B (en) |
SG (1) | SG11083G (en) |
SU (3) | SU660589A3 (en) |
ZA (1) | ZA767333B (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
US4370265A (en) * | 1974-10-22 | 1983-01-25 | Agence Nationale De Valorisation | Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
GB1571133A (en) * | 1976-04-26 | 1980-07-09 | Syntex Inc | Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof |
DE2862107D1 (en) | 1977-12-02 | 1982-11-18 | Takeda Chemical Industries Ltd | Glucosamine-peptide derivatives and their pharmaceutical compositions |
US4397844A (en) * | 1978-02-24 | 1983-08-09 | Ciba-Geigy Corporation | Antigen derivatives and processes for their preparation |
FI66878C (en) * | 1978-02-24 | 1984-12-10 | Ciba Geigy Ag | FOERFARANDE FOER FRAMSTAELLNING AV NYA ANTIGENDERIVAT |
FR2420545A1 (en) * | 1978-03-20 | 1979-10-19 | Anvar | NEW ESTERS OF N-ACETYL-MURAMYL-AMINOACYL-GLUTAMIC ACID OR SUBSTITUTION DERIVATIVES THEREOF WITH ANTI-INFECTIOUS PROPERTIES AND / OR IMMUNOLOGICAL ADJUVANTS |
FR2442241A2 (en) * | 1978-03-20 | 1980-06-20 | Anvar | NOVEL ESTER COMPOUNDS OF MURAMYL-PEPTIDE, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, IN PARTICULAR IN THE FORM OF LIPOSOMES |
FR2428050A1 (en) * | 1978-06-05 | 1980-01-04 | Anvar | OLIGOMERS OF MURAMYL-PEPTIDE COMPOUNDS AND DRUGS CONTAINING THEM |
FR2428051A1 (en) * | 1978-06-05 | 1980-01-04 | Anvar | NOVEL MURAMYL-PEPTIDE COMPOUNDS AND MEDICAMENTS CONTAINING THEM |
FR2446292A1 (en) * | 1979-01-12 | 1980-08-08 | Anvar | MURAMYL-PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM |
US4256735A (en) * | 1979-01-29 | 1981-03-17 | Merck & Co., Inc. | Immunologically active dipeptidyl saccharides and methods of preparation |
FR2449697A1 (en) | 1979-02-20 | 1980-09-19 | Anvar | NOVEL MURAMYL-PEPTIDES SUBSTITUTED ON PEPTIDE NITROGEN AND MEDICAMENTS CONTAINING THEM |
JPS55111499A (en) * | 1979-02-21 | 1980-08-28 | Takeda Chem Ind Ltd | Glucosamine derivative and its preparation |
JPS5618996A (en) * | 1979-06-21 | 1981-02-23 | Dai Ichi Seiyaku Co Ltd | Muramyldipeptide derivative |
FI75578C (en) | 1979-07-25 | 1988-07-11 | Ciba Geigy Ag | Analogous procedure for the preparation of pharmacologically acting lipophilic a phosphatidylmuramyl peptides. |
JPS5649396A (en) * | 1979-09-28 | 1981-05-02 | Dai Ichi Seiyaku Co Ltd | Novel muramyldipeptide derivative |
DE3070457D1 (en) * | 1979-10-02 | 1985-05-15 | Ciba Geigy Ag | Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production |
US4409209A (en) * | 1979-10-12 | 1983-10-11 | Ciba-Geigy Corporation | Novel phosphorylmuramyl peptides and processes for the manufacture thereof |
FI803077A (en) | 1979-10-12 | 1981-04-13 | Ciba Geigy Ag | FOERFARANDE FOER FRAMSTAELLNING AV MYRAMYLPEPTIDER |
US4406889A (en) * | 1980-02-15 | 1983-09-27 | Ciba-Geigy Corporation | Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use |
US4368190A (en) * | 1980-04-17 | 1983-01-11 | Merck & Co., Inc. | Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation |
US4310514A (en) | 1980-05-05 | 1982-01-12 | Merck & Co., Inc. | Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation |
EP0056560A1 (en) * | 1981-01-19 | 1982-07-28 | Ciba-Geigy Ag | Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics |
GR78246B (en) * | 1981-01-23 | 1984-09-26 | Ciba Geigy Ag | |
JPS6042398A (en) * | 1983-08-18 | 1985-03-06 | Toshiyuki Hamaoka | Muramyldipeptide active ester derivative |
EP0541486A1 (en) * | 1991-11-07 | 1993-05-12 | Ciba-Geigy Ag | Polycyclic conjugates |
JP4875612B2 (en) | 2005-04-27 | 2012-02-15 | 真司 武岡 | Cationic amino acid type lipid |
US10610564B2 (en) | 2015-02-26 | 2020-04-07 | Stc.Unm | IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy |
EP3387005B1 (en) * | 2015-12-10 | 2022-08-24 | Bharat Biotech International Limited | Novel muramyl peptide derivative compound, synthesis and uses thereof |
WO2017103944A1 (en) * | 2015-12-15 | 2017-06-22 | Bharat Biotech International Limited | Novel muramyl peptide derivative compound, synthesis and uses thereof |
WO2019040109A1 (en) | 2017-08-21 | 2019-02-28 | Celgene Corporation | Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
-
1975
- 1975-12-10 CH CH1604275A patent/CH613709A5/en not_active IP Right Cessation
-
1976
- 1976-12-08 DE DE19762655500 patent/DE2655500A1/en active Granted
- 1976-12-08 GB GB51228/76A patent/GB1570625A/en not_active Expired
- 1976-12-08 SU SU762428152A patent/SU660589A3/en active
- 1976-12-08 NL NL7613666A patent/NL7613666A/en not_active Application Discontinuation
- 1976-12-08 CA CA000267474A patent/CA1262400A/en not_active Expired
- 1976-12-08 GR GR52361A patent/GR61647B/en unknown
- 1976-12-09 CS CS768063A patent/CS205027B2/en unknown
- 1976-12-09 FI FI763541A patent/FI64164C/en not_active IP Right Cessation
- 1976-12-09 DK DK552476A patent/DK154654C/en not_active IP Right Cessation
- 1976-12-09 IE IE2689/76A patent/IE44190B1/en not_active IP Right Cessation
- 1976-12-09 NZ NZ182837A patent/NZ182837A/en unknown
- 1976-12-09 AT AT0909276A patent/AT365607B/en not_active IP Right Cessation
- 1976-12-09 CS CS768063A patent/CS205026B2/en unknown
- 1976-12-09 BE BE173091A patent/BE849214A/en not_active IP Right Cessation
- 1976-12-09 IL IL51076A patent/IL51076A/en unknown
- 1976-12-09 NO NO764191A patent/NO144850C/en unknown
- 1976-12-09 FR FR7637091A patent/FR2361902A1/en active Granted
- 1976-12-09 CS CS768063A patent/CS205025B2/en unknown
- 1976-12-09 HU HU76CI1702A patent/HU177970B/en unknown
- 1976-12-09 PT PT65946A patent/PT65946B/en unknown
- 1976-12-09 ZA ZA767333A patent/ZA767333B/en unknown
- 1976-12-09 SE SE7613851A patent/SE445923B/en not_active IP Right Cessation
- 1976-12-09 CS CS768063A patent/CS205028B2/en unknown
- 1976-12-09 DD DD7600196215A patent/DD129781A5/en unknown
- 1976-12-09 AU AU20422/76A patent/AU508764B2/en not_active Expired
- 1976-12-10 PL PL1976210827A patent/PL110787B1/en unknown
- 1976-12-10 ES ES454118A patent/ES454118A1/en not_active Expired
- 1976-12-10 PL PL1976194291A patent/PL110353B1/en not_active IP Right Cessation
- 1976-12-10 PL PL1976210828A patent/PL110794B1/en unknown
- 1976-12-10 AR AR265799A patent/AR224091A1/en active
- 1976-12-10 JP JP51147903A patent/JPS5273820A/en active Granted
- 1976-12-10 PL PL1976210826A patent/PL112672B1/en unknown
-
1977
- 1977-09-08 SU SU772521659A patent/SU747430A3/en active
- 1977-09-08 SU SU772518658A patent/SU1060118A3/en active
- 1977-09-30 AR AR269405A patent/AR220686A1/en active
- 1977-12-28 ES ES465514A patent/ES465514A1/en not_active Expired
-
1978
- 1978-08-24 CH CH898378A patent/CH614718A5/en not_active IP Right Cessation
-
1983
- 1983-03-14 SG SG110/83A patent/SG11083G/en unknown
- 1983-08-25 HK HK328/83A patent/HK32883A/en unknown
-
1984
- 1984-12-30 MY MY123/84A patent/MY8400123A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE44190L (en) | Glucosamine derivatives | |
EP1170016A3 (en) | Urease-based vaccine against helicobacter infection | |
NZ291262A (en) | E. coli heat-labile enterotoxin derivatives and their use as oral adjuvants | |
EP0362279A4 (en) | Saponin adjuvant. | |
CA2059692A1 (en) | Pneumoccoccal polysaccharide conjugate vaccine | |
CA976293A (en) | High molecular weight cyclic nitrile adduct compositions | |
WO1992006113A3 (en) | Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant | |
JPS5232949A (en) | Cold-setting organo-polysiloxane composition | |
EP0048422A3 (en) | Pili of pseudomonas aeruginosa and utilization of same as vaccines against infectionary p.aeruginosa | |
IE32991L (en) | Ambutyrosins | |
NO913131L (en) | IMMUNOGENIC CONJUGATES OF NON-TOXIC OLIGOSACCHARIDE FROM TABLE TELL PERTUSSIS LIPOOLYSACCHARIDE. | |
AU554859B2 (en) | Polymerized albumin vaccine | |
CA2273922A1 (en) | Novel saponin compositions and uses thereof | |
JPS51125728A (en) | Novel non-medical germicides and their preparation | |
JPS5668614A (en) | Abrin-containing agent for immunological enhancement | |
JPS5314788A (en) | Preparation of polyvinyl chloride | |
JPS5257293A (en) | Preparation of novel copolymers | |
DK0459176T3 (en) | Oligophosphates with antiviral action | |
JPS542398A (en) | Preparation of d-alpha-amino acid | |
JPS5384100A (en) | Preparation of photo-plymerizable silicone compound | |
FR2287912A1 (en) | Sepharose type polysaccharides with amino-acid, pref glycine, gps - useful as non-specific immunity adjuvants for vaccines | |
Umetani | Studies on the Vaccine of Rickettsia tsutsugamushi I: Influences of Storage conditions on the Immunogenicity of the Vaccine of Rickettsia tsutsugamushi | |
JPS52134094A (en) | Preparation of pseudo-oxynicotine | |
JPS5328101A (en) | Antibiotics as-85 and its preparation | |
JPS52136149A (en) | 3-epi-xk-88-5 as novel antibiotics and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |